The present invention provides a pharmaceutical composition comprising
N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine and
sulfobutyl ether .beta.-cyclodextrin or a salt thereof, wherein sulfobutyl
ether .beta.-cyclodextrin increases the solubility of
N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine and
improves the photostability.
La présente invention fournit une composition pharmaceutique comportant la beta.-cyclodextrine d'éther de N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine et de sulfobutyl ou un sel en, où la beta.-cyclodextrine d'éther de sulfobutyl augmente la solubilité de N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine et améliore le photostability.
